IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
120 hedge funds and large institutions have $542M invested in IVERIC bio, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 39 increasing their positions, 28 reducing their positions, and 18 closing their positions.
403% more call options, than puts
Call options by funds: $8.43M | Put options by funds: $1.68M
106% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 18
39% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 28
27% more capital invested
Capital invested by funds: $426M → $542M (+$116M)
19% more funds holding
Funds holding: 101 → 120 (+19)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$14.4M |
| 2 |
BlackRock
New York
|
+$11.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$9.18M |
| 4 |
PA
Perceptive Advisors
New York
|
+$6.41M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$5.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$19.2M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$10M |
| 3 |
CCM
Consonance Capital Management
New York
|
-$9.41M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$6.89M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$6.39M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HTC
126
Hershey Trust Company
Hershey,
Pennsylvania
| – | -$580K | -102,846 | Closed |
|
|
SSA
127
Schonfeld Strategic Advisors
New York
| – | -$295K | -52,200 | Closed |
|
|
GC
128
Gratus Capital
Atlanta,
Georgia
| – | -$282K | -50,000 | Closed |
|
|
OSAM
129
O'Shaughnessy Asset Management
Stamford,
Connecticut
| – | -$261K | -46,178 | Closed |
|
|
TOPU
130
Trustees of Princeton University
Princeton,
New Jersey
| – | -$230K | -40,705 | Closed |
|
|
TAS
131
TIFF Advisory Services
Radnor,
Pennsylvania
| – | -$164K | -28,179 | Closed |
|
|
MFS
132
Mirabella Financial Services
London,
United Kingdom
| – | -$129K | -22,791 | Closed |
|
|
WS
133
Wedbush Securities
Los Angeles,
California
| – | -$62K | -11,000 | Closed |
|
134
Simplex Trading
Chicago,
Illinois
| – | -$65.9K | -10,303 | Closed |
|
|
SIS
135
Sound Income Strategies
Ft Lauderdale,
Florida
| – | -$1K | -250 | Closed |
|
|
CG
136
Cutler Group
San Francisco,
California
| – | -$1K | -200 | Closed |
|
|
SIAG
137
Safeguard Investment Advisory Group
Corona,
California
| – | +$243 | +38 | New |
|
ISEE Hedge Fund Activity: Q4 2020 in Review
120 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2020, worth a combined $542M — up 27% from $426M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new ISEE positions and 18 closed out — a net gain of 19 holders — while 39 added to existing stakes and 28 trimmed.
The largest buyer was State Street, adding an estimated $14.4M. The largest seller was OrbiMed, exiting entirely with an estimated $19.2M sold.
- 120 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2020, up from 101 in Q3 2020.
- Funds reported $542M of IVERIC bio, Inc. Common Stock stock for Q4 2020, up 27% quarter-over-quarter.
- 37 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2020 and 18 closed out, a net change of +19 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q4 2020 was State Street, an estimated $14.4M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q4 2020 was OrbiMed, an estimated $19.2M sold.
Based on aggregated 13F filings for Q4 2020.